Advertisement
Blogs
Subscribe to Pharmaceutical Processing Blogs

The Lead

Where Will it End?

September 4, 2014 | by Mike Auerbach, Editor In Chief | Comments

I am grateful for many things in my life. But one thing that I just added to my list, and never considered before, is that I don’t have to figure out the shopping habits of American consumers.          

TOPICS:

Why Fitting a Square Plug in a Round Hole is Profitable for Pharma and Most Likely Will Stay

August 6, 2014 8:50 am | by Girish Malhotra, PE; President, EPCOT International | Comments

In 2005 I had raised a question about Batch or a Continuous Process: A Choice. At that time it seemed like a logical question and still is. However, I left part of the question unanswered. Missing was the discussion of components of pharma manufacturing, API manufacture and their formulations.

TOPICS:

Pharma Economics - 101

July 30, 2014 3:22 pm | by Mike Auerbach, Editor In Chief | Comments

There has always been much hand-wringing and shouting regarding the costs of new medications. Most of this comes from people outside the industry – politicians, public health advocates, and a smattering of those that just like to hear themselves talk.

TOPICS:

When Will We Learn?

July 23, 2014 3:11 pm | by Mike Auerbach, Editor In Chief | Comments

Humans are a strange lot. We are more than willing to believe just about any product claim in the hopes that an easy solution to our problem can be found inside a pill, tablet or liquid.           

TOPICS:
Advertisement

OpenFDA – the Good, the Bad, and the Ugly

July 21, 2014 3:39 pm | by Brian Overstreet, CEO, AdverseEvents | Comments

In an ideal world, OpenFDA could usher in a world of new and improved tools and products that would improve patient safety and adherence, increase physician awareness of drug safety dangers, assist healthcare decision makers who are driving prescribing behavior with better decision support, and lower the overall cost of care by reducing avoidable side effects. But we don’t live in an ideal world.

TOPICS:

Like Peanut Butter and Chocolate

July 16, 2014 3:02 pm | by Mike Auerbach, Editor In Chief | Comments

Some things just seem to naturally go together – peanut butter and chocolate is one of those combinations – especially in the form of peanut butter cups. Bacon and eggs is another, as is peanut butter and jelly, pizza and beer and numerous other tasty combinations.

TOPICS:

5 Places You May Have Hidden Paper on Your Shop Floor

July 11, 2014 7:56 am | by Greg Goodwin, Research Associate, LNS Research | Comments

If you’re currently planning on implementing a Manufacturing Execution System (MES) or other applications in the Manufacturing Operations Management (MOM) space, you may think you have all the shop-floor areas and situations that still use manual, paper-based processes identified, but this may not necessarily be the case.

It's All In The Delivery

June 30, 2014 11:45 am | by Mike Auerbach, Editor in Chief | Comments

There are times when you hold new technology in your hands and realize that you are looking at something special, something that will, to use an oft-cited cliché, be a “game-changer.”           

TOPICS:

Four Manufacturing Software Applications That Support Operational Agility

June 13, 2014 8:36 am | by Greg Goodwin, Research Associate, LNS Research | Comments

Chances are, an increased rate of production response to changes in supply and demand is high on your operational wish-list. And you’re not alone. When it comes to increased agility, it’s hard to argue there’s such a thing as too fast, and even small improvements in the ability to quickly ramp production up or down can translate to significant long-term bottom-line gains.

TOPICS:
Advertisement

As Pfizer Fights it Out in Britain, US Lawmakers are Making Their Move in the Long Game

May 16, 2014 9:03 am | by Brian Williamson, Managing Director, Jumpstart | Comments

While British attention in the Pfizer-AstraZeneca takeover battle has been focused on clashes between MPs and Pfizer chief executive Ian Read, events have been unfolding across the Atlantic which could have an infinitely greater bearing on where the pharma giant eventually conducts its business.

TOPICS:

How Consumer IT Trends are Affecting Manufacturing Software

May 15, 2014 9:02 am | by Greg Goodwin, Research Associate, LNS Research | Comments

It’s 2014, and that means there are a handful of ways you could be perusing this and any other sentences on your reading queue, daily to-do list, etc. While it’s certainly possible you printed it out, it’s far more likely that you’re viewing it on your desktop or laptop or, increasingly from smaller mobile devices like tablets or even your smartphone, perhaps with your window for your favorite game app temporarily minimized.

TOPICS:

Let’s Not Get Too Excited Over Pancreatic Cancer Drug Trial Results

May 7, 2014 3:50 pm | by Mike Auerbach, Editor in Chief | Comments

Last week there was much excitement and press coverage regarding the results of a Phase III drug study for pancreatic cancer. The company that developed the drug issued a press release, the Pancreatic Cancer Action Network issued a press release – both extolling the new drug’s ability to increase the life expectancy of those with pancreatic cancer.

TOPICS:

Small Workstations, Large Benefits

April 30, 2014 3:06 pm | by Julie Ackerman, Senior Director PR and Communications, PMMI, The Association for Packaging and Processing Technologies | Comments

Regardless of which stage a product is entering the pharmaceutical production line, keeping the work flow moving seamlessly without sacrificing safety and quality is paramount to any operation. Enter the compact workstation.     

TOPICS:

Smart Packaging

April 16, 2014 10:36 am | by Mike Auerbach, Editor-in Chief | Comments

While smart companies consider the final packaging of their product concurrently with the development of the product, sometimes it’s evident that even the smartest companies fail to consider every aspect of their packaging when it finally comes in contact with the consumer.

TOPICS:

Ranbaxy: Lessons and Opportunities

April 10, 2014 8:48 am | by Girish Malhotra, President, EPCOT International | Comments

Will Sun’s latest acquisition change the global pharma landscape, or result in yet another problem-filled “me too” pharma company?                    

TOPICS:

How Will Big Data Affect Manufacturing? Manufacturers Weigh In

April 2, 2014 4:00 pm | by Greg Goodwin, Research Associate, LNS Research | Comments

The current buzz-term “Big Data” may be slightly misleading in the strictest sense. The concept is nothing new. Most manufacturers are quite accustomed to having “big,” some might say huge, amounts of data flowing throughout their organizations, but have historically lacked the context that gives that data actionable meaning—giving birth to the oft used phrase, “data rich, but information poor.”

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading